Mami Takadate
Papers
1
Total Citations
5
H-Index
1
About
Mami Takadate is a leading figure in the advancement of robotic-assisted surgery, with a focused expertise in urological oncology and health economics. Her major contribution lies in pioneering the clinical and economic validation of the hinotori surgical system, a next-generation robotic platform developed in Japan. Through her landmark single-centre study, she provided the first comprehensive comparison between hinotori and the established da Vinci system for robot-assisted radical prostatectomy (RARP), demonstrating that hinotori achieves comparable oncologic and functional outcomes while offering potential cost savings. This work, cited 5 times since its 2025 publication, is already shaping surgical decision-making and healthcare policy in Japan. Takadate’s research bridges the critical gap between surgical innovation and real-world value, addressing both clinical efficacy and economic sustainability—a rare and vital perspective. Her findings are instrumental for hospitals evaluating new robotic platforms and for surgeons seeking evidence-based alternatives to established systems. As robotic surgery evolves, Takadate’s work ensures that progress is measured not only by technical prowess but by tangible benefits to patients and healthcare systems alike.
Research Focus
Key Achievements
Top Papers
- 1